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Pseudomonas aeruginosa has a high potential for developing resistance to multiple
antibiotics. The gene (glnS) encoding glutaminyl-tRNA synthetase (GlnRS) from P. aeruginosa
was cloned and the resulting protein characterized. GlnRS was kinetically evaluated and the KM
and kcatobs, governing interactions with tRNA, were 1.0 μM and 0.15 s-1, respectively. The
crystal structure of the α2 form of P. aeruginosa GlnRS was solved to 1.9 Å resolution. The
amino acid sequence and structure of P. aeruginosa GlnRS were analyzed and compared to that
of GlnRS from Escherichia coli. Amino acids that interact with ATP, glutamine, and tRNA are
well conserved and structure overlays indicate that both GlnRS proteins conform to a similar 3dimensional structure. GlnRS was developed into a screening platform using scintillation
proximity assay (SPA) technology and used to screen ~2000 chemical compounds. Three
inhibitory compounds were identified and analyzed for enzymatic inhibition as well as minimum
inhibitory concentrations (MIC) against clinically relevant bacterial strains. Two of the
compounds, BM02E04 and BM04H03, were selected for further studies. These compounds
displayed broad spectrum anti-bacterial activity and exhibited moderate inhibitory activity
against mutant efflux deficient strains of P. aeruginosa and E. coli. Growth of wild-type strains
were unaffected, indicating that efflux was likely responsible for the lack of sensitivity. The
global mode of action was determined using time-kill kinetics. BM04H03 did not inhibit growth
of human cell cultures at any concentration and BM02E04 only inhibit cultures at the highest
concentration tested (400 μg/ml). In conclusion, GlnRS from P. aeruginosa is shown to have a
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Abstract

inhibitors of P. aeruginosa GlnRS with the potential for utility as lead candidates in antibacterial
drug development in a time of increased antibiotic resistance.

Key words: glutaminyl-tRNA synthetase, protein synthesis, Pseudomonas aeruginosa,
aminoacyl-tRNA synthetase, drug discovery, antibiotics
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structure similar to that of E. coli GlnRS and two natural product compounds were identified as

In recent years, infectious diseases have become increasingly difficult to treat as a result of
resistance to therapeutic remedies by many bacteria. This antibiotic resistance is a major global
problem and has attracted a considerable amount of media attention. In a recent report from the
Centers for Disease Control and Prevention (CDC), it was estimated that at least 23,000
individuals die each year in the United States from infections caused by pathogens exhibiting
resistance to antibiotics.1 This public health threat can be attributed to several factors, including:
misuse as well as overuse of antibacterials in clinical as well as community settings, the tendency
of bacteria to acquire resistance due to acquisition of efflux systems, and the low permeability of
the bacterial membrane.2 Certain bacteria have become resistant to many antibiotics, and these
multidrug resistant (MDR) bacteria form a new group of “superbugs” in which there are no
known drugs to treat them.3 One pathogen in this group that is of specific concern is
Pseudomonas aeruginosa, an aerobic, Gram-negative bacteria that is a common cause of
healthcare-associated infections including pneumonia, urinary tract infections, and bloodstream
infections.4 The ability of this bacteria to form resilient biofilms on implanted medical devices
such as catheters, as well as on general hospital surfaces and water sources, poses a threat to
immunocompromised individuals resulting in higher mortality rates.5 Patents with cystic fibrosis
(CF) are especially at risk, as P. aeruginosa colonizes the lungs of these patients forming
biofilms which leads to chronic infections and is a leading cause of death.6
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INTRODUCTION

synthetase (aaRS), which functions by attaching amino acids to cognate tRNAs during protein
biosynthesis. GlnRS is a class I tRNA synthetase which is characterized by the presence of two
amino acid consensus sequences, HIGH and KMSKS, located in the active site of the catalytic
domain formed by the conserved Rossman fold. GlnRS, along with glutamyl-, and arginyltRNA synthetases (GluRS and ArgRS) are the only three aaRS requiring the presence of cognate
tRNA to form the aminoacyl-adenylate intermediate.7 These three tRNA synthetases are further
classified as subclass Ib enzymes due to similar subunit structures.8
Aminoacylation of a tRNA with the cognate amino acid occurs via a two-step esterification
reaction. First, an aminoacyl-adenylate intermediate is formed by the condensation of the amino
acid and ATP. Next, the amino acid is transferred to the 2’- or 3’- hydroxyl group of the
terminal adenosine of the cognate tRNA.9 The attachment of the correct amino acid to its
cognate tRNA is vital for the fidelity of protein synthesis. This process is known as tRNA
identity but different aaRSs have various different fidelity mechanisms to ensure
accuracy.10 Unlike many other tRNA synthetases, GlnRS has no independent internal editing
function to aid in discrimination of near-cognate amino acids such as asparagine or glutamic
acid.11 Instead, an induced fit binding mechanism for the binding specificity of glutamine (Gln)
by GlnRS is promoted by conformational changes that occur in the active site as a result of
binding the anticodon loop of tRNAGln.12 In addition, specific nucleotides that are considered to
be identity elements in tRNAGln promote correct tRNA recognition by the cognate synthetase.
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The glutaminyl tRNA-synthetase (GlnRS), encoded by the glnS gene, is an aminoacyl tRNA

cognate tRNAGln, and negative elements that block recognition of tRNAGln by non-cognate
synthetases.7 In addition to identity elements for binding the correct tRNA, competition by
various aaRS proteins for binding cognate tRNAs plays a key role in specificity.13 The
individual fit mechanism for binding specificity and the specific tRNAGln identify elements work
together to ensure fidelity.
GlnRS is one of only two out of twenty aaRS enzymes which is not found in all organisms,
and some prokaryotes lack a tRNA synthetase to attach glutamine to its cognate tRNAGln. When
this is the case, tRNAGln is mischarged by a non-discriminating (ND) GluRS resulting in GlutRNAGln. The mischarged tRNAGln is then converted to Gln-tRNAGln in an amidation reaction by
a heterotrimeric amidotransferase (AdT).14 In P. aeruginosa, GluRS is the discriminating type
and therefore does not attach a glutamic acid amino acid to tRNAGln, thus necessitating a
functional form of GlnRS.15
The gene encoding GlnRS from P. aeruginosa was cloned and the resulting over-expressed
protein was purified and the kinetic parameters (KM, Vmax and kcat) governing the interaction with
tRNAGln were determined. The crystal structure of the α2 form of GlnRS was solved to 1.9 Å
resolution. A high-throughput screening platform was then developed and optimized to screen
for potential anti-infectives using scintillation proximity assay (SPA) technology. Out of 2000
synthetic and natural chemical compounds, three compounds were identified that inhibited the
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The recognition is facilitated by positive elements that allow GlnRS to directly recognize

determination, two were selected for additional characterization.
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activity of P. aeruginosa GlnRS. From these three compounds, after scaffold analysis and MIC

Protein Expression and Characterization
The glutaminyl-tRNA synthetase gene (glnS) from P. aeruginosa was cloned, expressed and
the resulting protein was purified to greater than 98% homogeneity (Fig. S1). The
aminoacylation assay described under the “Methods and Materials” section was used to analyze
the activity of P. aeruginosa GlnRS and to determine the concentrations to be used in
downstream assays [Fig. 1(A)]. The aminoacylation reaction occurs via two distinct enzymatic
steps. First, binding of ATP and the cognate amino acid allows the formation of an aminoacyladenylate. This results from the condensation of the amino acid substrate, in this case glutamine,
and ATP, in which ATP is hydrolyzed releasing the β and γ phosphates as PPi. With all but three
of the aaRS enzymes (GluRS, GlnRS and ArgRS), this reaction can occur in the absence of the
tRNA and can be monitored using the ATP:PPi exchange assay to determine the kinetic
interaction of the enzyme with either ATP or the amino acid. The results of this assay are
indicative of the ability of the enzyme to form an aminoacyl-adenylate in the absence of tRNA
followed by reversal of the reaction and subsequent radioactive labeling of ATP in the presence
of saturating amounts of [32P]PPi. In this initial step, formation of an aminoacyl adenylate by
GlnRS is “non-productive” in the absence of tRNAGln, for reasons discussed in the next section.
To confirm the requirement for tRNAGln in the formation of an aminoacyl-adenylate by P.
aeruginosa GlnRS, the ATP:PPi exchange assay was monitored in the presence and absence of
tRNA [Fig. 1(B)]. In the absence of tRNAGln [Fig. 1(B), Lane 1] there was no [32P]ATP formed
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RESULTS

formed. However, in the presence of increasing concentrations of tRNAGln, increased levels of
[32P]ATP were detected [Fig. 1(B), lane 2-4]. This indicated that in the presence of tRNA an
aminoacyl-adenylate was formed. However, the low level of radioactive ATP formed suggests
that the reversal of the reaction is not a dynamic process, likely because the reaction goes to
fulfillment and the tRNA is aminoacylated.
Next, the kinetic interactions of P. aeruginosa GlnRS with its cognate tRNA substrate were
determined using the aminoacylation assay. The initial rate for aminoacylation was determined at
several concentrations of tRNAGln (0.5-2 µM) while holding the concentrations of ATP and Gln
constant at 2.5 mM and 100 μM, respectively [Fig. 1(C)]. The initial velocities were modeled by
fitting them to the Michaelis-Menten steady-state model using XLfit (IDBS). The KM and the
observed enzyme turn-over values (kcatobs) were determined to be 1.0 μM and 0.15 s-1 for P.
aeruginosa GlnRS, which gave a kcatobs/KM value of 0.15 s-1µM-1. The same values determined
for Escherichia coli GlnRS were 0.15 µM, 0.2 s-1, and 0.95 s-1µM-1, respectively.16 The minor
variation in the KM values could be a result of the codon usage or tRNAGln isotype concentration
variation found in P. aeruginosa relative to that in E. coli.

Structure and Sequence Analysis
P. aeruginosa GlnRS incubated with MgCl2 and AMPPNP crystallized into space group P2
and crystals diffracted to 1.9 Å resolution with a single homodimer in the asymmetric unit [Fig.
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by the reversal of the condensation reaction. This indicated that no aminoacyl-adenylate had

conditions and AMPPNP and L-glutamine in the soaking conditions, no evidence of any ligand
was observed in the electron density. Data collection and refinement statistics are given in Table
I. P. aeruginosa GlnRS formed a typical GlnRS structure containing five distinct domains:
dinucleotide fold domain (DNF), acceptor stem binding domain (ABD), helical sub-domain,
proximal beta-barrel, and distal beta-barrel [Fig. 2(B)].
The structure of E. coli GlnRS with ATP and tRNAGln (PDB ID: 1GSG), with a glutaminyladenylate analog and tRNAGln (PDB ID: 1QTQ) or without any ligands (PDB ID: 1NYL) have
been well studied, primarily from the 3-dimensional structures of GlnRS from E. coli.17-19 More
recently, the structure of GlnRS from Deinococcus radiodurans has been solved.20 This protein,
albeit similar to the E. coli GlnRS, contains a unique C-terminal Yqey domain and will not be
discussed here. A comparison of the amino acid primary structure of E. coli and P. aeruginosa
GlnRS reveals a high degree of sequence conservation and the residues that come in direct
contact with ATP, glutamine, and tRNAGln are highly conserved (Fig. 3). This is consistent with
alignment studies where a high level of sequence conservation was observed (average 68/56%
similar/identical residues) when GlnRS was compared with 33 GlnRS proteins across the
eubacterial phylum (Table S1). Interestingly, the greatest variation occurred when the amino
acid sequence of P. aeruginosa GlnRS was compared with that of GlnRS from the
epsilonproteobacteria phyla, in which there was only 47.3/38.6 similar/identical residues. The
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2(A)] (PDB ID: 5BNZ). Despite the presence of MgCl2 and AMPPNP in the crystallization

specificity in substrate selection likely occurs in a similar fashion in these enzymes.
The DNF domain contains the catalytic active site of GlnRS and it is composed of two
sections separated by the ABD domain. The first half contains the signature HIGH motif, while
the KMSKS motif is contained within the second half of the DNF domain (Fig. 3). This active
site region contains binding sites for ATP and glutamine as well as the acceptor stem of tRNAGln.
The amino acids observed to form contacts with these substrates in the DNF of E. coli GlnRS are
almost strictly conserved in the P. aeruginosa GlnRS (Fig. 4). During the process of substrate
binding, certain amino acid residues in the ABD make contact with the acceptor stem, guiding it
through conformational rearrangements to the active site in the DNF domain.12 There is a high
degree of sequence conservation seen in the alignment in Figure 3, and the residues contacting
the acceptor stem of the tRNA in E. coli GlnRS are conserved or similar in the P. aeruginosa
enzyme.
The mechanism of identification of the cognate amino acid and discrimination of noncognate amino acids allows the aminoacyl tRNA synthetases to be divided into two groups. The
aaRS enzymes in the first group have a proofreading function in the form of an editing domain
that ensures cognate acylation of tRNA. The editing occurs either at the pre-transfer state, in
which the mis-activated amino acid-adenylate is hydrolyzed before attachment to the 3’-end of
the cognate tRNA, or at the post-transfer state, in which the non-cognate amino acid of the
mischarged tRNA is hydrolyzed.21 The other group of aaRS enzymes ensure cognate acylation
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high level of sequence conservation indicates that recognition of the substrates and insurance of

as a result of structural rearrangements in the active site induced by cognate tRNA binding.17
This precludes the binding of other potential amino acid substrates besides glutamine and
glutamic acid. To distinguish between glutamine and glutamic acid, two residues in the active
site are essential (Fig. 4): Arg30 (E. coli numbering) recognizes the carbonyl carbon of
glutamine through electrostatic interactions, and Tyr211 acts as a “negative determinant” against
binding of glutamic acid by potentially forming hydrogen bounds with the two amide hydrogens
of glutamine, thereby stabilizing binding.11,18 These residues are strictly conserved between E.
coli and P. aeruginosa GlnRS.
The anticodon of the tRNA is a major determinate for selection of the cognate tRNA, and the
two carboxyl-terminal domains of GlnRS make contacts with this region of the tRNA, acting to
discriminate in favor of binding tRNAGln out of the pool of tRNAs.19 The three nucleotides
composing the anticodon interact with specific amino acid residues. First, there are two
isoacceptors for tRNAGln (CUG and UUG). The pocket for binding either U34 or C34
accommodates either of the pyrimidines, but discriminates against a purine.22 Within the pocket
U34/C34 appears to form hydrogen bonds with Arg410/Arg412 (P. aeruginosa/E. coli), allowing
a certain amount of wobble room. Next, U35 has a tight binding pocket and movement is limited
by interactions with a number of amino acid residues. Arg412, Lys401, and Arg520 (E. coli
numbering) stabilize U35 through ionic interactions with the two adjacent phosphates. Arg520
also packs against one side of U35 and forms a hydrogen bond with the 2-keto of the uracil base.
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of tRNA by a process other than editing. In the case of E. coli, GlnRS binds ATP and glutamine

Glu519 recognize U35 by forming hydrogen bonds with the 4-keto group, N3, and the 2-keto
group, respectively, of the uracil ring. Finally, G36 fits into a pocket specific for the guanosine,
which is recognized by hydrogen bonding of the guanidinium group of Arg402 to N7 and the 6keto group of guanine.22 All of these amino acid residues making contact with the anticodon are
strictly conserved in GlnRS from both E. coli and P. aeruginosa (Fig. 5) indicating a similar
mechanism of action.

Screening for Inhibitors of P. aeruginosa GlnRS Activity
Using SPA technology, the activity of GlnRS in the aminoacylation assay was screened
against three chemical compound libraries to identify inhibitory compounds. First, a collection
of 320 natural products, mostly derived from plants, was from the Prestwick Phytochemical
Library. The second was the NatProd Collection from Microsource Discovery Systems,
composed of 800 natural products, including simple and complex oxygen heterocycles, alkaloids,
sesquiterpenes, diterpenes, pentacyclic triterpenes, and sterols. Finally, the Anti-infective
Library from TimTec, LLC contained 890 low molecular weight synthetic compounds with
scaffolds based on known anti-bacterial, anti-fungal, and anti-microbial agents. The assay
detects the ability of GlnRS to aminoacylate tRNAGln and to measure the effect of a chemical
compound on the aminoacylation activity. Chemical compounds were dissolved in 100%
dimethyl sulfoxide (DMSO) resulting in final DMSO concentrations of 4% in the screening
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Pro369 packs against the other side of U35, holding it rigidly in place. Arg341, Gln517, and

aminoacylation assay at increasing amounts. There was no decrease of activity observed in the
aminoacylation assays containing up to 7% DMSO and only a moderate decrease in activity to
10% DMSO [Fig. 6(A)]. Next, tRNA was titrated into the assay to determine the concentration
of tRNAGln to be used in the screening assay with the goal of insuring that the amount of
tRNAGln used would be within the linear region of the reaction-detection time [Fig. 6(B)]. From
the titration reactions, ~1 μM tRNAGln was selected for use in the screening assays. The other
components of the assay were also optimized for maximum activity (Fig. S2). The chemical
compound concentration in the initial screening assays was 132 μM and screening was carried
out as single point assays. Compounds observed to inhibit at least 50% of enzymatic activity
were re-assayed in triplicate. These assays resulted in three confirmed hit compounds,
BM02E04, BM04B05, and BM04H03, all from the natural product library (Fig. 7). Initially, the
potency of the compounds for inhibiting the enzymatic activity of GlnRS was determined (Fig.
8). To do this, the compounds were titrated into aminoacylation assays, resulting in
concentrations of compound ranging from 200 μM to 0.4 μM. The IC50 values for BM02E04,
BM04B05, and BM04H03 were determined to be 1.9, 2.5, and 40 μM, respectively.
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assays. To determine the effect on the enzymatic activity, DMSO was added to the

The three hit compounds were tested in broth microdilution assays to determine minimum
inhibitory concentrations (MIC) against a panel of 10 pathogenic bacteria, including efflux pump
mutants of E. coli and P. aeruginosa and a hypersensitive strain of P. aeruginosa (Table S2).
Quality control of test antibiotics was monitored by testing against the same panel of bacteria
(Table S3). BM02E04 inhibited the growth of all Gram-positive organisms: Staphylococcus
aureus and Streptococcus pneumoniae at 64 µg/ml and Enterococcus faecalis at 4 µg/ml.
BM04H03 inhibited growth of E. faecalis, S. aureus and S. pneumoniae with MIC values of 64,
8, and 64 µg/ml. These two compounds, BM02E04 and BM04H03, had good MICs against the
Gram-negative Moraxella catarrhalis (32 and 0.125 µg/ml, respectively). Interestingly, cultures
of the respiratory pathogen, Haemophilus influenzae, were only slightly affected by the
compounds. BM02E04 exhibited a modest MIC against the mutant form of E. coli (E. coli tolC),
while BM04H03 showed a significant decrease in the MIC value against the efflux deficient
stain. When compared with the lack of inhibition of the wild-type strain, this indicated that
efflux was a likely mechanism for the lack of sensitivity. Both compounds were also observed to
have a low level of activity against P. aeruginosa PA200, the efflux pump mutant, and the
hypersensitive strain, again indicating that the lack of sensitivity of the wild-type P. aeruginosa
may be due to efflux. There was no activity observed against the wild-type strains of either E.
coli or P. aeruginosa at concentrations below 128 µg/ml. Based on compound scaffold analysis
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Microbiological Assays

the compounds, BM02E04 and BM04H03 were selected for further analysis.
Next, time kill kinetic studies were performed to determine the global mode of inhibition of
bacterial growth in cultures. Based on MIC results, both compounds were tested against cultures
of the Gram-positive bacteria, S. aureus, and the Gram-negative M. catarrhalis. All cultures
contained compounds at four times the MIC and samples were analyzed between 0 and 24 hours
[Fig. 9(A), 9(B)]. Both BM02E04 and BM04H03 were observed to inhibit S. aureus with a
bacteriostatic global mode of inhibition. They displayed constant growth but a decrease in
colony forming units (CFU) of 2 to 6 log10 compared to the control during the initial six hours.
BM04H03 was also observed to inhibit growth of the Gram-negative M. catarrhalis, with a
bacteriostatic mode of inhibition. However, BM02E04 was bactericidal when tested against M.
catarrhalis and inhibited bacterial growth by killing the bacteria.
MTT assays were performed to examine whether the hit compounds BM02E04 and
BM04H03 were cytotoxic to human cells, and if they were toxic, to determine the concentration
at which growth was inhibited by 50% (CC50). Human embryonic kidney 293 (HEK293) cells
were treated with concentrations of each compound separately at 25-400 µg/ml for 24 hours
under standard tissue culture conditions in triplicate. There was only a slight decrease in cell
viability in the presence of BM02E04 at the highest concentration tested (400 μg/ml) and
BM04H03 was not observed to be toxic to cells at any concentration tested [Fig. 9(C), 9(D)].
The low level of toxicity observed in these early tests is advantageous in development of

This article is protected by copyright. All rights reserved.

1469896x, 2020, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/pro.3800 by The University Of Texas Rio Grande Vallley, Wiley Online Library on [28/10/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

and broad spectrum activity against both Gram-positive and Gram-negative pathogens, two of

development as therapeutics.

DISCUSSION
The aminoacyl-tRNA synthetases are essential components of protein synthesis and are vital
for cell growth in all organisms. In the quest for discovery of new and different agents with
which to fight bacterial infections, it is important that the molecular targets upon which these
agents act be sufficiently distinct when compared with the eukaryotic homolog. The group of
aaRS enzymes from bacterial origins as a whole are divergent in amino acid primary structure
compared with that of eukaryotic counterparts. This difference makes them good targets for
development of new antibacterial agents. When P. aeruginosa GlnRS was compared with the
human cytosolic form of GlnRS (hGlnRS), there was only 40.6/31.8% similar/identical amino
acids observed. However, this is a bit misleading since the hGlnRS contains an N-terminal 200
amino acid domain that functions in the formation of a multi-synthetase complex that is not part
of the bacterial GlnRS.23 When this domain was removed from the amino acid sequence of
hGlnRS and the truncated polypeptide was compared with the full amino acid sequence of P.
aeruginosa GlnRS, the percentage of similar/identical residues increased to 57.5/45.0,
respectively. This degree of amino acid sequence similarity observed between human and P.
aeruginosa GlnRS is higher than the similarity between eukaryotic and prokaryotic aaRS
enzymes in general. However, when BM02E04 and BM04H03 were tested in human cell
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potential antimicrobial agents and indicates that both compounds may be amenable to further

target the human enzyme and do have good potential for development as therapeutic agents. The
amino acid sequence of P. aeruginosa GlnRS, when compared to homologs from other members
of the eubacteria phyla contained ~68/56% similar/identical sequence conservation. This
increased level of sequence conservation may argue for broad spectrum activity against various
bacteria, which is also supported by the finding in MIC testing that these compounds were
observed to be active against both Gram-negative and Gram-positive pathogens.
We show here the three-dimensional crystal structure for P. aeruginosa GlnRS solved to 1.9
Å, which allows identification and comparison of regions critical for enzymatic function relative
to the well-studied E. coli enzyme. The structure of E. coli GlnRS was previously solved bound
to each of the three substrates (ATP, glutamine, and tRNAGln) which allows us to directly
compare essential amino acid residues making contact with the substrates. In this comparison,
we found that the critical amino acid residues were structurally conserved, indicating likely
conservation of function as well as structure.
Scintillation proximity assay technology was used to develop a screen for inhibitors of the
activity of P. aeruginosa GlnRS. The screening assays were robust and resulted in Z’ and Z
factors of approximately 0.55 and 0.33, respectively, across all plates. The signal to background
ratio of the unaffected enzyme activity to the EDTA controls was approximately 6:1. From over
2000 compounds, 5 compounds from the TimTec LLC compound library and 15 from the
MicroSource Discovery Systems were identified that inhibited the activity of P. aeruginosa
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cultures, there was almost a complete absence of toxicity, indicating these compounds did not

aeruginosa, three compounds, BM02E04, BM04B05, and BM04H03, were chosen for additional
analysis. All three compounds exhibited inhibition of enzymatic activity. However, structure
analysis and the lack of activity against bacteria in culture resulted in the removal of BM04B05
from further consideration. BM02E04 and BM04H03 exhibited moderate MICs against Grampositive bacteria as well as against efflux mutant forms of E. coli and P. aeruginosa. Time-kill
studies indicated that these two compounds were bacteriostatic against cultures of S. aureus.
This would be the expected mode of action for compounds that inhibit the activity of an aaRS,
since inhibition of the aminoacylation activity mimics starvation for amino acids by lowering the
ratio of charged to uncharged tRNA, and induces the stringent response resulting in static
bacterial growth. BM04H03 was also bacteriostatic against cultures of the Gram-negative M.
catarrhalis. However, BM02E04 displayed a bactericidal mode of inhibition in these bacterial
cultures. The bactericidal form of inhibition observed with BM02E04 may be due to inhibition
of secondary roles and functions as well as inhibition of the aminoacylation function. Many
secondary roles have been observed for members of the aaRS group of enzymes.24
A search of PubChem identified BM02E04 as purpurogallin-4-carboxylic acid (CID:
269315). There is little data on the bioactivity of this compound, but it has been shown to be
active as an anti-oxidant and in PubChem bioassays (AID:1259374) to decrease the activity of
human microphthalmia-associated transcription factor. The core scaffold (purpurogallin) is a
natural phenol, and has shown activity in numerous PubChem bioassays.
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GlnRS. After removing compounds that had activity against multiple aaRS enzymes from P.

Cryptotanshinone, a diterpene quinone, is isolated from the roots of the plant Salvia miltiorrhiza
Bunge and has been widely used in traditional Chinese medicine for treatment of a variety of
diseases. Recently, cryptotanshinone has been shown to have anti-cancer activity.25 The finding
that these natural product compounds are bio-active in a number of assays, may reduce the
potential for development as an antibacterial, since this may increase the likelihood of toxicity.
However, cryptotanshinone has been shown to be well tolerated in numerous clinical settings.
As noted above, both BM02E04 and BM04H03 were observed to have moderate MIC values
against the three Gram-positive bacteria, E. faecalis, S. aureus, and S. pneumoniae. This is an
interesting observation since these three organisms do not contain a GlnRS enzyme, instead they
contain a non-discriminating (ND) GluRS, which charges both tRNAGlu and tRNAGln with
glutamic acid. The ND-GluRS from these three Gram-positive bacteria as well as GlnRS from
numerous other eubacteria (see Table S1) must all recognize tRNAGln as a cognate tRNA. When
we carried out BLAST searches against the E. faecalis, S. aureus, and S. pneumoniae databases
using the P. aeruginosa GlnRS amino acid sequence as the query sequence, the ND-GluRS
proteins were the primary hits. The “sequences producing significant alignments” portion of the
various ND-GluRS proteins in the BLAST results ranged from 303 amino acid residues to the
full length proteins, and in the alignments with the corresponding amino acid sequence of GlnRS
from P. aeruginosa revealed a high degree of conservation. In particular, we aligned the overall
amino acid sequence of GlnRS from P. aeruginosa with that of the ND-GluRS from S.
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BM04H03 was identified in PubChem as cryptotanshinone (CID: 160254).

(71/60 %, similar/identical) as observed when the sequence of P. aeruginosa GlnRS was
compared with the amino acid sequence of GlnRS from other eubacteria (Table S1). It is an
intriguing possibility that inhibition by these compounds of the growth of these bacteria in
culture may be the result of inhibition of the ND-GluRS proteins. Further work will be
necessary to determine whether BM02E04 and BM04H03 also target the ND-GluRS proteins of
these bacteria.

METHODS AND MATERIALS
Materials
All chemicals were obtained from Fisher Scientific (Pittsburg, PA). DNA oligonucleotides
were from Integrated DNA Technologies (Coralville, IA). DNA sequencing was performed by
Functional Bioscience (Madison, WI). Radioactive isotopes, SPA beads and 96-well screening
plates were from PerkinElmer (Waltham, MA). The natural compound libraries were from
MicroSource Discovery Systems (Gaylordsville, CT) and Prestwick Chemical, Inc. (StrasbourgIllkirch, France), and the synthetic compound library was from TimTec LLC (Newark, DE).
Compounds stocks were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mM,
stored at –20°C and thawed immediately before analysis. The compounds had an average purity
of 95%, and the minimum purity is at least 90%.
Cloning and Purification
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pneumoniae (accession VTQ31436), the results indicated a similar conservation of amino acids

GlnRS (MJ Mini Thermo Cycler, Bio-Rad, Hercules, CA) using P. aeruginosa PAO1 (ATCC
47085) genomic DNA as a template. An NheI restriction site was added at the 5’ end of the gene
using a forward primer (5’-CCAAGCTAGCAAGCCAGAGACCACC-3’) and a HindIII
restriction site was added at the 3’ end using a reverse primer (5’CAACAAGCTTTCAGCCCTGTCCCCAG -3’). The amplified gene was inserted into the pET28b(+) plasmid (Novagen) digested with NheI and HindIII restriction enzymes. This recombinant
plasmid was transformed into E. coli Rosetta 2 (DE3) Singles Competent Cells (EMD Millipore,
Danvers, MA).
Bacterial cultures were grown in Terrific Broth (TB) containing 25 µg/mL of kanamycin and
50 µg/mL of chloramphenicol at 37°C. At an optical density (A600) of 0.6 the overexpression of
P. aeruginosa GlnRS was induced by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG)
to a concentration of 0.5 mM. The culture was grown for 4 hours post-induction and bacteria
were harvested by centrifugation (10,000 g, 4°C, 45 min). Fraction I lysates were prepared26 and
purification of P. aeruginosa GlnRS was initiated by addition of ammonium sulfate (AS) to 60%
saturation resulting in precipitation of the target enzyme. P. aeruginosa GlnRS was further
purified using nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography (Perfect Pro, 5
Prime)27 and then dialyzed twice against a buffer (2L) containing: 20 mM Hepes-KOH (pH 7.0),
40 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, and 10% glycerol. Purified protein were aliquoted
and flash frozen in liquid nitrogen.
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Polymerase chain reaction (PCR) was used to amplify the gene encoding P. aeruginosa
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For sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), 4-12%
polyacrylamide precast gradient gels (Novex NuPAGE; Invitrogen) were used with 3-(Nmorpholino)propanesulfonic acid (MOPS) as the running buffer (Invitrogen). The gels were
stained with Simply Blue Safe Stain (Invitrogen) to visualize the proteins. The protein standard
was the EZ-Run Rec Ladder (Fisher Scientific). Coomassie Protein Assay Reagent (Thermo
Scientific, Waltham, MA) was used to determine protein concentrations with bovine serum
albumin as a standard.

ATP:PPi Exchange Reactions
ATP:PPi exchange reactions (100 μL) were carried out at 37ºC for 20 min in 50 mM TrisHCl (pH 7.5), 10 mM KF, 8 mM MgOAc, 1 mM dithiothreitol (DTT), 2 mM [32P]PPi (50
cpm/pmol), 2 mM ATP, 2 mM glutamine and 0.2 μM of P. aeruginosa GlnRS as described.15
The reactions were carried out in the absence and in the presence of tRNAGln (0.3, 0.6, 1.2 μM).

Timed tRNA Aminoacylation Assay
Aminoacylation reactions were used to determine initial velocities at various concentrations
of tRNAGln. These reactions were carried out at 37ºC and stopped at time intervals ranging from
1 to 5 minutes. Reactions (50 µL) contained a component mixture to yield final concentrations
of 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 2.5 mM ATP, 1 mM DTT, 75 μM [3H]Gln (50

This article is protected by copyright. All rights reserved.

1469896x, 2020, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/pro.3800 by The University Of Texas Rio Grande Vallley, Wiley Online Library on [28/10/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

Gel Electrophoresis and Protein Assays

tRNAGln at varied concentrations (0.5 to 2.0 μM). Reactions were stopped by the addition of 2
ml of 5% (v/v) ice-cold trichloroacetic acid (TCA), placed on ice for 10 min, and then filtered
through glass fiber filters (Millipore, type HA 0.45 mm). Filters were washed with 10 mL icecold 5% TCA and dried. The filters were analyzed using an LS6500 multi-purpose scintillation
counter (Beckman Coulter). Initial velocities for aminoacylation were calculated for all tRNA
concentrations. Data were fit to the Michaelis-Menten steady-state model to determine the KM
and Vmax values.

Crystallography and Structure Determination
P. aeruginosa GlnRS was cloned, expressed, and purified for crystallography as described.28
In preparation for crystallography, the GlnRS protein was concentrated to 20.0 mg/ml (SSGCID
batch ID PsaeA.18222.aB1.PW37623), and incubated with 2.5 mM MgCl2 and 2.5 mM
AMPPNP for 10 min at 290 K. Crystals were then grown at 290 K by sitting drop vapor
diffusion with 0.4 μl of protein/ligand complex mixed with 0.4 μl of a condition based on
Microlytic MCSG1, well c2:23% (w/v)PET-3350, 0.2 M lithium sulfate, and 0.1 M Bis-Tris:HCl
(pH 6.5). Crystals were looped and soaked in reservoir solution supplemented with 20%
ethylene glycol, 2.5 mM L-glutamine, 2.5 mM MgCl2, and 2.5 mM AMPPNP and flash frozen in
liquid nitrogen. Data were collected at 100 K on a Rayonix MX-225 mm CCD detector at a
wavelength of 0.97872 Å on beamline 21-ID-F at Life Sciences Collaborative Access Team (LS-
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cpm/pmol), and 0.025 μM P. aeruginosa GlnRS. Reactions were initiated by addition of

XDS/XSCALE package (REF).29 The structure was solved using molecular replacement with
BALBES30 and 1NYL as a starting model. Iterative rounds of manual model building and
automated refinement were carried out using Coot31 and Phenix.32 The structure was quality
checked with Molprobity.33

Chemical Compound Screening
The tRNA aminoacylation assay was developed into a screening platform for identification
of inhibitory compounds using scintillation proximity assay (SPA) technology. Screening
reactions were carried out in 96-well microtiter plates. Test compounds, dissolved in 100%
DMSO (2 μL of compound; 3.3 mM), were equilibrated by addition of 33 μL of the component
mixture described above and incubated at ambient temperature for 15 min. Control reactions
contained DMSO in the absence of compound. Other control assays to yield an assay baseline
were carried out in the presence of 50 μM ethylenediaminetetraacetic acid (EDTA). The
concentration of P. aeruginosa GlnRS was 0.12 μM. Reactions were initiated by the addition of
15 μL E. coli tRNA (~1.0 μM tRNAGln) and incubated for 1 h at 37ºC. Reactions were stopped
by the addition of 5 µL of 0.5 M EDTA. 400 μg of yttrium silicate (Ysi) poly-L-lysine coated
SPA beads (Perkin-Elmer) in 150 μL of 300 mM citric acid were added to the reaction and
allowed to incubate at room temperature for 1 h. Reactions were analyzed using a 1450
Microbeta (Jet) liquid scintillation/luminescent counter (Wallac). Assays to determine IC50
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CAT) at the Advanced Photon Source (APS, Argonne, IL, USA). Data were reduced with the

IC50 was determined by fitting the data to a Sigmoidal Dose-Response Model using XLfit
(IDBS).

Microbiological Assays
Broth microdilution minimum inhibitory concentration (MIC) testing was carried out
according to Clinical Laboratory Standards Institute guidelines M7-A7.34 MIC values were
determined against a panel of bacteria which included: E. coli (ATCC® 25922), E. coli TolC
mutant, Enterococcus faecalis (ATCC® 29212), Haemophilus influenzae (ATCC® 49766),
Moraxella catarrhalis (ATCC® 25238), P. aeruginosa (ATCC® 47085), P. aeruginosa PAO200
(efflux pump mutant), P. aeruginosa hypersensitive strain (ATCC® 35151), Staphylococcus
aureus (ATCC® 29213), and Streptococcus pneumonia (ATCC® 49619).
Time-kill studies were performed using M. catarrhalis and S. aureus based on the MIC assay
results, according to CLSI document M26-A.35 Growth media was Brain Heart Infusion and
Trypticase Soy Broth from Remel (Lenexa, KS). The compound concentration was four times
the MIC.

In Vitro Cytotoxicity Test
The toxic effect of each compound on the growth of human cell cultures was determined as
described using human embryonic kidney 293 cells (HEK-293).15 MTT assays were carried out
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values were performed with the test compounds serially diluted from 200 μM to 0.4 μM. The

test was utilized to assess statistical significance.

Supplemental Material
•

Supplemental Figure S1. Purification of P. aeruginosa GlnRS.

•

Supplemental Figure S2. Titration of non-enzymatic components into the aminoacylation
assay for determination of the concentration to be used in the screening assays.

•

Supplemental Table 1. Comparison of the amino acid sequence of P. aeruginosa GlnRS
with the homolog from various other eubacteria.

•

Supplemental Table 2. MIC values of the hit compounds observed to inhibit the activity
of P. aeruginosa GlnRS.

•

Supplemental Table 3. The MIC of control antibiotics against the panel of pathogenic
bacteria were tested for quality control.
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Data collection
5BNZ
50-1.90 (1.95-1.90)
P2

PDB code
Resolution (Å)
Space Group
Unit Cell Dimensions
• a, b, c (Å)
• α, β, γ, (˚)
No. of unique reflections
R,merge
Redundancy
Completeness (%)
l/σ
CC1/2
Resolution (Å)
No. of protein atoms

109.01 56.02 127.14 187.24
90.00, 99.41, 90.00
119747
9.5 (46.1)
5.0 (5.0)
99.8 (99.6)
11.71 (3.31)
99.7 (83.9)
Refinement
1.90 (1.95-1.90)
8743

No. of sulfate atoms

20

No. of Cl atoms
No. of water molecules
Rworking (Rfree)
R.M.S. deviations
• Bond lengths (Å)
• Bond angles (°)
Ave. B factors (Å2)
• Protein
• Sulfate
• Cl
• Water
Ramachandran plot
• Favored region
• Allowed regions
• Outlier regions

2
1522
18.8 (22.8)
0.007
1.006
20.92
52.93
46.82
32.23
98.57
1.17
0.27
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Table 1
Data collection and refinement statistics for the crystal structure of P. aeruginosa GlnRS.

Figure 1. Characterization of P. aeruginosa GlnRS. (A) P. aeruginosa GlnRS was titrated
into the aminoacylation assay as described in “Methods and Materials” at concentrations
between 0.005 and 0.5 μM. Background activity was minimal and was subtracted from values at
all concentrations of GlnRS. (B) ATP:PPi exchange reaction to determine the requirement for
the cognate tRNA in the formation of an aminoacyl adenylate by P. aeruginosa GlnRS. The
reactions contained 0, 0.3, 0.6, 1.2 µM tRNAGln in lanes 1, 2, 3, and 4, respectively. (C)
Determination of the kinetic parameters with respect to tRNAGln for P. aeruginosa GlnRS in the
aminoacylation reaction. Initial velocities were determined and the data were fit to a MichaelisMenten steady-state model using XLfit (IDBS) to determine Km and Vmax.

Figure 2. The crystal structure of P. aeruginosa GlnRS. (A) The 3-dimensional structure of
P. aeruginosa GlnRS was solved to 1.9 Å resolution (PDB ID: 5BNZ) as a single α2 homodimer
in the asymmetric unit. (B) Each monomer contained five distinct domains: dinucleotide fold
domain (DNF) (blue), acceptor stem binding domain (ABD) (green), helical sub-domain
(magenta), proximal beta-barrel (salmon), and distal beta-barrel (yellow).

Figure 3. Amino acid sequence alignment of P. aeruginosa and E. coli GlnRS. The protein
sequences were downloaded from the National Center for Biotechnology Information (NCBI).
Accession numbers for GlnRS protein sequences of E. coli and P. aeruginosa are P00962 and
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Figure Legends

11.5.3 (Invitrogen). Identical amino acid residues are white letters on black background and
similar residues are black letters on grey background. The positions of the HIGH and KMSKS
motifs are boxed. Amino acid residues that interact with Gln (♦), ATP (●) and tRNA (■/□,
acceptor stem/anticodon) are indicated.

Figure 4. Comparison of the active site structures of P. aeruginosa and E. coli GlnRS. In
the overlay, P. aeruginosa GlnRS is shown in blue and E. coli GlnRS is shown in magenta. The
aminoacyl adenylate mimic (Gln-AMS) backbone is shown in green and the acceptor stem of
tRNAGln is shown in gold. Amino acid residues interacting with the two substrates are labeled
(P. aeruginosa/E. coli numbering).

Figure 5. Comparison of the anticodon binding regions of GlnRS from P. aeruginosa and
E. coli. In the overlay, P. aeruginosa GlnRS is shown in blue and E. coli GlnRS is shown in
magenta. The three nucleotides forming the anticodon of the tRNA are labeled (C34, U35, and
G36). The anticodon of tRNAGln is shown in gold. Amino acid residues interacting with the
nucleotides forming the anticodon are labeled (P. aeruginosa/E. coli numbering).

Figure 6. Screening assay development. (A) Effect of DMSO in the P. aeruginosa GlnRS
aminoacylation assay. DMSO (0-10%) was added into the aminoacylation assay described in the
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Q9I2U8, respectively. Sequence alignments were performed using Vector NTI Advance (TM)

tRNA concentration to be used in screening assays and to determine that the amount of tRNAGln
used would be within the linear region of the reaction-detection time, tRNA was added into the
aminoacylation assay described in the “Chemical Compound Screening” section of “Methods
and Materials”. The activity was monitored using SPA technology.

Figure 7. The chemical structure of the hit compounds. The structure of (A) BM02E04, (B)
BM04H03, and (C) BM04B05.

Figure 8. Determination of the IC50 values of the hit compounds. IC50 values for the
inhibitory potency of (A) BM02E04, (B) BM04B05, and (C) BM04H03 against the
aminoacylation activity of P. aeruginosa GlnRS were 1.9 μM, 2.5 μM, and 40 μM, respectively.
The compounds were serially diluted from 200 µM to 0.4 µM into aminoacylation assays
containing P. aeruginosa GlnRS at 0.12 μM. The “% Positive” indicates the percent of activity
observed relative to activity in assays where only DMSO was added to the assay in the absence
of compound. The curve fits and IC50 values were determined using the Sigmoidal DoseResponse Model in XLfit 5.3 (IDBS).

Figure 9. Activity of BM02E04 and BM04H03 in microbiological assays. The activity of the
hit compounds against the growth of cultures containing (A) S. aureus, and (B) M. catarrhalis
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“Chemical Compound Screening” section of “Methods and Materials”. (B) To determine the

added to bacterial cultures at 4×MIC. Samples were analyzed by plating and determination of
colony forming units (CFU) at 0, 2, 4, 6 and 24 h. Diamonds (♦) represent cultures containing
BM04H03 and squares (■) represent cultures containing BM02E04. Circles (●) represent
growth of control cultures containing only DMSO in the absence of compound. Toxicity of (C)
BM02E04 and (D) BM04H03 were measured using human embryonic kidney 293 (HEK-293)
cell cultures. The compound concentrations ranged from 25 to 400 µg/ml. The data points
represents an average value for assays carried out in triplicate. The “% Positive” indicates the
percent of cell growth observed relative to growth in assays where only DMSO was added to the
cells in the absence of compound.
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bacteria were determined using broth microdilution susceptibility testing. Compounds were
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